Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125424281 | 12542428 | 1 | I | 20160705 | 20160708 | 20160708 | PER | US-ASTRAZENECA-2016SE73550 | ASTRAZENECA | 0.00 | F | Y | 71.70000 | KG | 20160709 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125424281 | 12542428 | 1 | PS | NEXIUM 24HR | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | BANZ | 21153 | 44.6 | MG | CAPSULE | QD | ||||||
| 125424281 | 12542428 | 2 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | N | 0 | ||||||||||
| 125424281 | 12542428 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125424281 | 12542428 | 1 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125424281 | 12542428 | Drug ineffective | |
| 125424281 | 12542428 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125424281 | 12542428 | 1 | 2015 | 0 |